Amarin Corporation plc is a biopharmaceutical company focused on therapeutics to improve cardiovascular health.
Amarin Corporation is a leading biopharmaceutical company dedicated to transforming cardiovascular health. With a focus on innovative therapeutics, Amarin Corporation is committed to enhancing the scientific understanding of cardiovascular risk and advancing treatments for patients globally. Amarin Corporation operates with a global presence, with offices at 440 Route 22, Suite 300, Bridgewater, NJ 08807, US, and Gotthardstrasse 2, Zug, ZG 6300, CH, along with partners and suppliers worldwide.
Amarin Corporation's commitment extends to pioneering research and development in cardiovascular disease management, seeking to improve patient outcomes beyond traditional therapies. The company strives to meet the evolving needs of healthcare professionals and patients, offering cutting-edge solutions that address critical gaps in cardiovascular care.
Amarin Corporation is poised for continued growth and innovation in the biopharmaceutical sector. We invite the manager of Amarin Corporation to create a customized and exclusive company showcase and product listing on our platform to further enhance your market presence.
Other organizations in the same industry
This company is also known as